Angiogenesis induction and regression in human surgical wounds

被引:86
作者
Brown, NJ
Smyth, EAE
Cross, SS
Reed, MWR
机构
[1] Univ Sheffield, Acad Unit Surg Oncol, Div Clin Sci, Sheffield, S Yorkshire, England
[2] Univ Sheffield, Sect Oncol & Pathol, Div Genom Med, Sheffield, S Yorkshire, England
关键词
D O I
10.1046/j.1524-475X.2002.10408.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Angiogenesis in human wound healing is not well characterized, with only sparse information available regarding the maturation and fate of vessels formed as a consequence of human tissue repair. Therefore, this study aimed to establish the temporal profile of angiogenesis in human dermal wounds. Punch biopsies were obtained under local anesthesia from 45 patients following breast surgery. Scars were predominantly between 2 and 52 weeks after surgery but in five patients were > 52 weeks. Control samples were taken from breast skin peroperatively (n =24). Quantification of vascular density was performed using the Chalkley grid, following antibody staining for platelet endothelial cell adhesion molecule. Vascular patterns, wound cellularity and morphology were also determined. Cumulative microvessel density was increased in all samples when compared to controls (p < 0.05). This was greatest 2 to 24 weeks following surgery 17 (15-21) median (range), decreased thereafter, but remained elevated compared to controls even in the mature scars > 52 weeks. Control tissue showed an ordered morphological arrangement of dermal structures, collagen, and elastic fibers. However, wounding resulted in marked structural distortion for up to 15 weeks. In conclusion, this study shows for the first time the prolonged persistence of both microvessels and cellularity (fibroblastic cells), in addition to structural distortion in human dermal wounds, which is in contrast to previous in vitro and in vivo studies.
引用
收藏
页码:245 / 251
页数:7
相关论文
共 37 条
[1]  
[Anonymous], 2014, SCI TRANSL MED, DOI DOI 10.1126/scitranslmed.3009337
[2]   ANGIOGENESIS IN WOUND-HEALING [J].
ARNOLD, F ;
WEST, DC .
PHARMACOLOGY & THERAPEUTICS, 1991, 52 (03) :407-422
[3]  
AUGUSTIN HG, 1995, AM J PATHOL, V147, P339
[4]  
AUSPRUNK DH, 1978, LAB INVEST, V38, P284
[5]   Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].
Carmeliet, P ;
Moons, L ;
Luttun, A ;
Vincenti, V ;
Compernolle, V ;
De Mol, M ;
Wu, Y ;
Bon, F ;
Devy, L ;
Beck, H ;
Scholz, D ;
Acker, T ;
DiPalma, T ;
Dewerchin, M ;
Noel, A ;
Stalmans, I ;
Barra, A ;
Blacher, S ;
Vandendriessche, T ;
Ponten, A ;
Eriksson, U ;
Plate, KH ;
Foidart, JM ;
Schaper, W ;
Charnock-Jones, DS ;
Hicklin, DJ ;
Herbert, JM ;
Collen, D ;
Persico, MG .
NATURE MEDICINE, 2001, 7 (05) :575-583
[7]  
Crowther M, 2001, J LEUKOCYTE BIOL, V70, P478
[8]  
DESMOULIERE A, 1995, AM J PATHOL, V146, P56
[9]   Hypoxia regulates the expression of vascular permeability factor vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin [J].
Detmar, M ;
Brown, LF ;
Berse, B ;
Jackman, RW ;
Elicker, BM ;
Dvorak, HF ;
Claffey, KP .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (03) :263-268
[10]  
DiPietro LA, 1996, AM J PATHOL, V148, P1851